Andreas Skiöld

Andreas Skiöld discloses dealings in Medica Clinical Nord Holding AB to Finansinspektionen. In total, 6 filings cover trades dated from 26 August 2016 to 9 October 2017.

Every open-market trade on record is a purchase: 6 purchases worth €29k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2017: 3 purchases and no sales on the market.

A typical purchase (the median) is worth €4,180. On 2 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 10 October 2017 with an open-market purchase (€1,740) in Medica Clinical Nord Holding AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.